What's new

Human medicines European public assessment report (EPAR): Trumenba, meningococcal group b vaccine (recombinant, adsorbed), Date of authorisation: 24/05/2017, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Trumenba, meningococcal group b vaccine (recombinant, adsorbed), Date of authorisation: 24/05/2017, Revision: 19, Status: Authorised

Apr 14, 2025 - 09:56
 0
Human medicines European public assessment report (EPAR): Trumenba, meningococcal group b vaccine (recombinant, adsorbed), Date of authorisation: 24/05/2017, Revision: 19, Status: Authorised
Human medicines European public assessment report (EPAR): Trumenba, meningococcal group b vaccine (recombinant, adsorbed), Date of authorisation: 24/05/2017, Revision: 19, Status: Authorised
Read More

Tags:

Previous Article

Vietnam's Golden Visa Ambition to 23-Million Tourist Target

Next Article

India risks missing US textile opportunity amid QCO hurdles

Related Posts

EMEA-003237-PIP02-22

EMEA-003237-PIP02-22

Mar 6, 2025  0

Human medicines European public assessment report (EPAR): Bavencio, avelumab, Date of authorisation: 18/09/2017, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 9, 2025  0

Medicinal products for human use: monthly figures - Jan...

Feb 25, 2025  0